TMDX TransMedics Group, Inc.

Nasdaq transmedics.com


$ 121.95 $ -0.22 (-0.18 %)    

Tuesday, 11-Nov-2025 13:28:51 EST
QQQ $ 621.55 $ 0.93 (0.15 %)
DIA $ 479.06 $ 4.95 (1.04 %)
SPY $ 682.92 $ 2.94 (0.43 %)
TLT $ 89.97 $ 0.03 (0.03 %)
GLD $ 378.16 $ -1.85 (-0.49 %)
$ 122.39
$ 122.97
$ 121.74 x 6
$ 122.39 x 8
$ 121.25 - $ 123.50
$ 55.00 - $ 145.50
639,073
na
4.18B
$ 1.38
$ 45.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 10-29-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 03-11-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 03-17-2020 12-28-2019 10-K
25 11-08-2019 09-28-2019 10-Q
26 08-08-2019 06-29-2019 10-Q
27 06-12-2019 03-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-transmedics-group-raises-price-target-to-147

Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the price target ...

 piper-sandler-maintains-overweight-on-transmedics-group-lowers-price-target-to-140

Piper Sandler analyst Matt O'Brien maintains TransMedics Group (NASDAQ:TMDX) with a Overweight and lowers the price targ...

 transmedics-group-raises-fy2025-sales-guidance-from-585000m-605000m-to-595000m-605000m-vs-600848m-est

TransMedics Group (NASDAQ:TMDX) raises FY2025 sales outlook from $585.000 million-$605.000 million to $595.000 million-$605.000...

 transmedics-gr-q3-eps-066-beats-035-estimate-sales-143823m-miss-145256m-estimate

TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.35 ...

 needham-upgrades-transmedics-group-to-buy-announces-148-price-target

Needham analyst Mike Matson upgrades TransMedics Group (NASDAQ:TMDX) from Hold to Buy and announces $148 price target.

 canaccord-genuity-maintains-buy-on-transmedics-group-maintains-142-price-target

Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy and maintains $142 price tar...

 jefferies-initiates-coverage-on-transmedics-group-with-buy-rating-announces-price-target-of-145

Jefferies analyst Young Li initiates coverage on TransMedics Group (NASDAQ:TMDX) with a Buy rating and announces Price Targe...

 transmedics-group-unit-acquires-145m-fixed-wing-aircraft-from-teaghlach-aviation-expands-fleet-to-22-for-national-organ-transport-program

Subsequently, on October 3, 2025, the Buyer acquired a fixed-wing aircraft from Teaghlach Aviation, LLC for a purchase price of...

 if-you-invested-100-in-transmedics-group-stock-5-years-ago-you-would-have-this-much-today

TransMedics Group (NASDAQ: TMDX) has outperformed the market over the past 5 years by 37.76% on an annualized basis producing a...

 transmedics-and-mercedes-benz-partner-to-launch-first-dedicated-organ-transplant-ground-transportation-network-across-italy-with-modern-v-class-fleet

Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program ("NOP") hubs in Italy...

 evercore-isi-group-initiates-coverage-on-transmedics-group-with-outperform-rating-announces-price-target-of-155

Evercore ISI Group analyst Daniel Markowitz initiates coverage on TransMedics Group (NASDAQ:TMDX) with a Outperform rating a...

 stifel-initiates-coverage-on-transmedics-group-with-hold-rating-announces-price-target-of-115

Stifel analyst Thomas Stephan initiates coverage on TransMedics Group (NASDAQ:TMDX) with a Hold rating and announces Price T...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION